Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 23 Apr 2023
Despite Improvement Efforts, the "State of the Air" Report Highlights Issues.
Read Full NewsOlder adults with chronic disease who have less education, lower income, and no active jobs tend to experience symptoms of depression.
A retrospective study suggests a high burden of prolonged, mostly low-grade infections in patients with multiple myeloma who receive T-cell-engaging therapies.
A national cohort study compares the safety and efficacy of weight-based and fixed-dose pembrolizumab regimens in patients with advanced non-small cell lung cancer.
Trastuzumab pamirtecan, a HER2-targeted antibody-drug conjugate, achieved ‘exceptional’ antitumor responses in patients with recurrent endometrial cancer, especially those with HER2 IHC 3+ tumors.
1.
In MDS at Lower Risk, Novel Therapy Diminished Transfusion Dependency.
2.
Experts Discuss Groundbreaking Advances in EGFR-Mutant Lung Cancer
3.
An FDA panel supports the use of CAR T-cell therapy earlier in the treatment of multiple myeloma.
4.
New First-Line Option for Advanced ALK-Positive Lung Cancer
5.
Cardiomyocytes are shielded from chemotherapy damage by mitochondrial proteins.
1.
Unlocking Life Expectancy After Subdural Hematoma: A New Hope
2.
Case Study: The Role of Machine Learning in the Detection of Skin Cancer
3.
Understanding Hemosiderosis: Causes, Symptoms, and Treatment Options
4.
The Benefits and Risks of Transurethral Resection of Bladder Tumor
5.
Optimizing Oncology Practice Revenue: Billing Software, Payer Trends, and Financial Navigation Tools
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- The Conclusion
2.
Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment
3.
Navigating the Complexities of Ph Negative ALL - Part V
4.
Current Scenario of Cancer- Final Discussion on the Importance of Genomic Testing & Advancement in Diagnosis and Treatment
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge